Actinium Pharmaceuticals
ATNM
#10013
Rank
C$60.03 M
Marketcap
C$1.91
Share price
-7.89%
Change (1 day)
-0.06%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -C$52.85 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are C$0.09 Million. In 2024 the company made an earning of -C$57.57 Million, an increase over its 2023 earnings that were of -C$70.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$52.85 Million-8.2%
2024 -C$57.57 Million-18.87%
2023 -C$70.97 Million52.24%
2022 -C$46.62 Million36.61%
2021 -C$34.12 Million11.48%
2020 -C$30.61 Million1.46%
2019 -C$30.17 Million-7.37%
2018 -C$32.57 Million-11.46%
2017 -C$36.79 Million10.67%
2016 -C$33.24 Million15.7%
2015 -C$28.73 Million-14.86%
2014 -C$33.75 Million129.19%
2013 -C$14.73 Million-8.55%
2012 -C$16.1 Million
2010 C$0.01 M-152.15%
2009 -C$0.03 Million-39.8%
2008 -C$0.04 Million120.29%
2007 -C$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-C$50.84 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.26 M-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.65 B-1,392.20%๐Ÿ‡บ๐Ÿ‡ธ USA